**Core Concept**
Chemoradiation combines chemotherapy and radiation therapy to treat cancer. However, radiation can increase the toxicity of chemotherapy, making management crucial. The drug in question aims to mitigate this effect.

**Why the Correct Answer is Right**
Amifostine is a cytoprotective agent that reduces the toxicity of chemotherapy and radiotherapy. It works by scavenging free radicals and depleting glutathione, thereby reducing oxidative stress and damage to healthy cells. Amifostine also inhibits the uptake of platinum-based chemotherapeutic agents by tumor cells, reducing their effectiveness but also decreasing the side effects.

**Why Each Wrong Option is Incorrect**
**Option A:**
This option is incorrect because it does not have a well-established role in reducing the toxicity of chemoradiation.

**Option B:**
This option is incorrect because it is actually a chemotherapeutic agent, which would increase the toxicity of chemoradiation rather than reduce it.

**Option C:**
This option is incorrect because it is primarily used as an anxiolytic and anticonvulsant, and does not have a role in reducing the toxicity of chemoradiation.

**Clinical Pearl / High-Yield Fact**
Amifostine is a cytoprotective agent that can reduce the toxicity of chemotherapy and radiotherapy, but it may also reduce the effectiveness of certain chemotherapeutic agents. This should be considered when selecting a treatment regimen.

**Correct Answer:** D. Amifostine.